Track Nautilus Biotechnology Inc (NAUT) Stock Price, Quote, latest community messages, chart, news and other stock related information. May AM · Trade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$k Buying A Few More Shares. . Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human. SEATTLE, May 23, (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein. Historical Prices for Nautilus Biotechnology ; 05/30/24, , , , ; 05/29/24, , , ,
Based on the average yearly growth of the Nautilus Biotechnology, Inc. stock in the last 10 years, the NAUT stock forecast for the beginning of next year is $. Stock analysis for Nautilus Biotechnology Inc (NAUT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. NAUT | Complete Nautilus Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Nautilus Biotechnology, Inc. - $NAUT STOCK NEWS ; 09/06/ AM · % ; 08/04/ AM · % ; 08/02/ AM · % ; 07/11/ AM · NAUT's current price target is $ Learn why top analysts are making this stock forecast for Nautilus Biotechnology at MarketBeat. Find out the direct holders, institutional holders and mutual fund holders for Nautilus Biotechnology, Inc. (NAUT). Get Nautilus Biotechnology Inc (NAUT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. NAUTILUS BIOTECHNOLOGY, INC. NAUT | stock. $ %. $ M. %. $ - Exchanges: NASDAQ. Sector: Health Care. Industry: Biotech Pharma. No company. The current market capitalization of Nautilus Biotechnology is $M. What is Nautilus Biotechnology's annual earnings per share (EPS)?. Nautilus. SEATTLE, Jan. 26, (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis.
Nautilus Biotechnology market cap as of June 17, is $B. Compare NAUT With Other Stocks. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. NAUT Stock Overview · Revenue is forecast to grow % per year · Makes less than USD$1m in revenue ($0) · Earnings are forecast to decline by an average of 20%. 27d. Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference ; 50d. NAUT Stock Earnings: Nautilus Biotechnology Beats. Nautilus Biotechnology, Inc.'s stock symbol is NAUT and currently trades under NASDAQ. It's current price per share is approximately $ Nautilus Biotechnology's latest funding round was a Corporate Minority - P2P for $M on July 28, Nautilus Biotechnology's valuation in June was. Discover real-time Nautilus Biotechnolgy, Inc. Common Stock (NAUT) stock prices, quotes, historical data, news, and Insights for informed trading and. Complete Nautilus Biotechnology Inc. stock information by Barron's. View real-time NAUT stock price and news, along with industry-best analysis. According to 2 analysts, the average rating for NAUT stock is "Hold." The month stock price forecast is $, which is an increase of % from the latest.
Historical daily share price chart and data for Nautilus Biotechnology since adjusted for splits and dividends. The latest closing stock price for. NASDAQ GS: NAUT ; Price. $ ; Change. + (+%) ; Volume. 31, ; 52 Week High. $ ; 52 Week Low. $ Stock price history for Nautilus Biotechnology (NAUT). Highest end of day price: $ USD on Lowest end of day price: $ USD on Latest News for Nautilus Biotechnology Stock (NASDAQ:NAUT) · Tuesday, April 30, · Friday, March 29, · Wednesday, February 28, · Thursday. The biotech company Nautilus Biotechnology Inc trades as NAUT stock on the Nasdaq All Markets. Nautilus (Nasdaq: NAUT) is a company with a vision to.